4.2 Article

The role of miR-101 in esophageal and gastric cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Pathways and role of MALAT1 in esophageal and gastric cancer

Athanasios Syllaios et al.

Summary: Research is focused on identifying the molecular mechanisms underlying esophageal cancer and gastric cancer, along with finding new therapeutic targets and biomarkers. Current literature indicates that long non-coding RNAs play important regulatory roles in the carcinogenesis and progression of these cancers, with MALAT1 being a widely studied lncRNA in this context.

ONCOLOGY LETTERS (2021)

Article Biochemistry & Molecular Biology

E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer

Tania Rossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1

Liang Wang et al.

CELL AND BIOSCIENCE (2018)

Article Biotechnology & Applied Microbiology

The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies

Jianpei Hu et al.

ONCOTARGETS AND THERAPY (2017)

Article Medicine, Research & Experimental

miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2

Jie Bao et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Cell Biology

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

A. Sacconi et al.

CELL DEATH & DISEASE (2012)

Article Multidisciplinary Sciences

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Sooryanarayana Varambally et al.

SCIENCE (2008)